HHS pulls millions in funding for Moderna to develop bird flu vaccines

Published May 29, 2025 11:03am ET



The Department of Health and Human Services cut over $750 million in funding for Moderna to develop an mRNA bird flu vaccine for humans.

The Biden administration awarded the vaccine manufacturer a $590 million grant in January from the Biomedical Advanced Research and Development Authority. The funding followed another $176 million award for an mRNA-based H5N1 avian influenza vaccine that HHS granted Moderna in July 2024.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.